# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Avenue Therapeutics shares are trading lower by 28.5% during Wednesday's session. The company is implementing a 1-for-75 re...
Avenue expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement ...